Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 4/2016

01-04-2016 | Editorial

Ghost busting—taking the sheet off the ghost

Authors: Robert J. Moots, Kate Wilson, Earl D. Silverman, on behalf of the International Rheumatology Editors

Published in: Rheumatology International | Issue 4/2016

Login to get access

Excerpt

Ghost authorship, defined as when an individual has made a substantial contribution to writing, conducting research for or editing of a manuscript, but is neither listed as an author nor appropriately acknowledged in the paper, is a cause for concern in biomedical publishing. A reader needs to be confident that the paper they are reading is the work of those prepared to take responsibility for it. …
Literature
1.
2.
Wislar JS, Flanagin A, Fontanarosa PB, Deangelis CD (2011) Honorary and ghost authorship in high impact biomedical journals: a cross sectional survey. BMJ 25(343):d6128. doi:10.​1136/​bmj.​d6128 CrossRef
3.
4.
5.
Flanagin A, Carey LA, Fontanarosa PB et al (1998) Prevalence of Articles With Honorary Authors and Ghost Authors in Peer-Reviewed Medical Journals. JAMA 280(3):222–224CrossRefPubMed
6.
Metadata
Title
Ghost busting—taking the sheet off the ghost
Authors
Robert J. Moots
Kate Wilson
Earl D. Silverman
on behalf of the International Rheumatology Editors
Publication date
01-04-2016
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 4/2016
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-016-3439-x

Other articles of this Issue 4/2016

Rheumatology International 4/2016 Go to the issue

Review Article - Pathology Review

Focal bone involvement in inflammatory arthritis: the role of IL17

Original Article - Genes and Disease

TLR9 polymorphisms and systemic lupus erythematosus risk: an update meta-analysis study

Original Article - Biomarkers

Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease

Original Article - Validation Studies

Cross-cultural validation of the paediatric Gait, Arms, Legs, Spine (pGALS) tool for the screening of musculoskeletal disorders in Mexican children

Original Article - Genes and Disease

The IL-33 gene is related to increased susceptibility to systemic sclerosis

Original Article - Validation Studies

Mapping health assessment questionnaire disability index (HAQ-DI) score, pain visual analog scale (VAS), and disease activity score in 28 joints (DAS28) onto the EuroQol-5D (EQ-5D) utility score with the KORean Observational study Network for Arthritis (KORONA) registry data
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits